Robust growth of human immunodeficiency virus type 1 (HIV-1)

被引:23
作者
Kim, H [1 ]
Yin, J [1 ]
机构
[1] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA
基金
美国国家科学基金会;
关键词
D O I
10.1529/biophysj.104.058438
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The persistence of human immunodeficiency virus type-1 (HIV-1) has long been attributed to its high mutation rate and the capacity of its resulting heterogeneous virus populations to evade host immune responses and antiviral drugs. However, this view is incomplete because it does not explain how the virus persists in light of the adverse effects mutations in the viral genome and variations in host functions can potentially have on viral functions and growth. Here we show that the resilience of HIV-1 can be credited, at least in part, to a robust response to perturbations that emerges as an intrinsic property of its intracellular development. Specifically, robustness in HIV-1 arises through the coupling of two feedback loops: a Rev-mediated negative feedback and a Tat-mediated positive feedback. By employing a mechanistic kinetic model for its growth we found that HIV-1 buffers the effects of many potentially detrimental variations in essential viral and cellular functions, including the binding of Rev to mRNA; the level of rev mRNA in the pool of fully spliced mRNA; the splicing of mRNA; the Rev-mediated nuclear export of incompletely-spliced mRNAs; and the nuclear import of Tat and Rev. The virus did not, however, perform robustly to perturbations in all functions. Notably, HIV-1 tended to amplify rather than buffer adverse effects of variations in the interaction of Tat with viral mRNA. This result shows how targeting therapeutics against molecular components of the viral positive-feedback loop open new possibilities and potential in the effective treatment of HIV-1.
引用
收藏
页码:2210 / 2221
页数:12
相关论文
共 88 条
[11]   REGULATION BY HIV REV DEPENDS UPON RECOGNITION OF SPLICE SITES [J].
CHANG, DD ;
SHARP, PA .
CELL, 1989, 59 (05) :789-795
[12]   Nuclear RNA export pathways [J].
Cullen, BR .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (12) :4181-4187
[13]  
CULLEN BR, 1991, ANNU REV MICROBIOL, V45, P219
[14]   THE HIV-1 REV PROTEIN - PROTOTYPE OF A NOVEL CLASS OF EUKARYOTIC POSTTRANSCRIPTIONAL REGULATORS [J].
CULLEN, BR ;
MALIM, MH .
TRENDS IN BIOCHEMICAL SCIENCES, 1991, 16 (09) :346-350
[15]   Retroviruses as model systems for the study of nuclear RNA export pathways [J].
Cullen, BR .
VIROLOGY, 1998, 249 (02) :203-210
[16]   FUNCTIONAL-ANALYSIS OF CAR, THE TARGET SEQUENCE FOR THE REV PROTEIN OF HIV-1 [J].
DAYTON, ET ;
POWELL, DM ;
DAYTON, AI .
SCIENCE, 1989, 246 (4937) :1625-1629
[17]   Strategies in the design of antiviral drugs [J].
De Clercq, E .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) :13-25
[18]  
Domingo E, 2001, Prog Drug Res, V57, P77
[19]   INEFFICIENT SPLICEOSOME ASSEMBLY AND ABNORMAL BRANCH SITE SELECTION IN SPLICING OF AN HIV-1 TRANSCRIPT IN-VITRO [J].
DYHRMIKKELSEN, H ;
KJEMS, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) :24060-24066
[20]   The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties [J].
Efthymiadis, A ;
Briggs, LJ ;
Jans, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) :1623-1628